Predicting Longitudinal Cognitive Decline and Alzheimer’s Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers

Predicting Longitudinal Cognitive Decline and Alzheimer’s Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers

The increasing burden of Alzheimer’s disease (AD) emphasizes the need for effective diagnostic and therapeutic strategies. Despite available treatments targeting amyloid beta (Aβ) plaques, disease-modifying therapies remain elusive. Early detection of mild cognitive impairment (MCI) patients at risk...

Full description

Bibliographic Details
Main Authors: Min-Koo Park, Jinhyun Ahn, Young-Ju Kim, Ji-Won Lee, Jeong-Chan Lee, Sung-Joo Hwang, Keun-Cheol Kim
Format: Article
Language:English
Published: MDPI AG 2024-06-01
Series:Cells
Subjects:
plasma biomarker
neuropsychological measure
linear mixed model
cognitive decline
MCI-to-AD conversion
Online Access:https://www.mdpi.com/2073-4409/13/13/1085

Internet

https://www.mdpi.com/2073-4409/13/13/1085

Similar Items